
Cogent Biosciences, Inc.
USD38.45
-0.29 (-0.75%)
CEO
Andrew R. Robbins
IPO Date
2018-03-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.84
Prev. Close
$38.74
Day Low
$38.15
Day High
$38.87
52W Low
$7.07
52W High
$43.73
Market Cap
$6.57B
Volume
0.09M
| 18 Feb 2026 |
| Piper Sandler |
| Overweight |
| Overweight |
| maintain |
| 21 Jan 2026 | Wedbush | Outperform | Outperform | maintain |
| 6 Jan 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 19 Dec 2025 | JP Morgan | Overweight | Overweight | maintain |
| 8 Dec 2025 | Needham | Hold | Hold | maintain |
| 13 Nov 2025 | HC Wainwright & Co. | Buy | Buy | maintain |
| 11 Nov 2025 | Baird | Neutral | Neutral | maintain |